DIFFUSE HEMISPHERIC GLIOMA, H3G34 MUTANT

Clinical trials for DIFFUSE HEMISPHERIC GLIOMA, H3G34 MUTANT explained in plain language.

Never miss a new study

Get alerted when new DIFFUSE HEMISPHERIC GLIOMA, H3G34 MUTANT trials appear

Sign up with your email to follow new studies for DIFFUSE HEMISPHERIC GLIOMA, H3G34 MUTANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for young brain cancer patients in groundbreaking trial

Disease control Not yet recruiting

This study is testing whether adding a new drug called ADI-PEG 20 to standard radiation and chemotherapy can help control aggressive brain tumors in children, teens, and young adults. The first part will find the safest dose, and the second part will see if the combination helps …

Matched conditions: DIFFUSE HEMISPHERIC GLIOMA, H3G34 MUTANT

Phase: PHASE1, PHASE2 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

DIFFUSE HEMISPHERIC GLIOMA, H3G34 MUTANT

Get alerted when new DIFFUSE HEMISPHERIC GLIOMA, H3G34 MUTANT trials appear

New hope for young brain cancer patients in groundbreaking trial